![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » FDA Issues Alert for Preloaded Syringes
FDA Issues Alert for Preloaded Syringes
February 1, 2005
The FDA has issued a nationwide alert against the use of all IV Flush brand preloaded syringes containing either heparin or sodium chloride because the products have not received proper clearance and may be contaminated.
There have been reports of infections that may have been caused by the heparin flushes, but the cases are still being investigated, the alert said.
The syringes, distributed by Pinnacle Medical Supply of Rowlett, Texas, were recalled by the company because they lacked FDA clearance. The syringes were sold to distributors who redistributed them to hospitals and other medical distributors. The syringe label reads, in part, "IV Flush Dallas, TX."
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct